查看購物車
  • Simplified Chinese
  • English
  • Japanese
關節重建設備市場：全球按產品、程序、類型、程序和最終用戶分類 - 預測至 2030 年
市場調查報告書
商品編碼
1660047

關節重建設備市場：全球按產品、程序、類型、程序和最終用戶分類 - 預測至 2030 年

Joint Replacement Devices Market by Product, Surgery, Type, Procedure type, End user - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 376 Pages | 訂單完成後即時交付

價格

全球關節重建裝置市場規模預計將從 2024 年的 234.2 億美元成長到 2030 年的 310.9 億美元，2024 年至 2030 年的複合年成長率為 4.8%。

製造過程中使用 3D 列印、引入智慧植入以及增加獲得最新創新植入的機會等技術進步正在支持關節重建設備市場的成長。此外，運動傷害的增加以及導致破壞性關節損傷的事故發生率的增加，導致對關節重建裝置的需求增加。

研究範圍
調查年份 2022-2030
基準年 2023
預測期 2024-2030
單元 美元
部分 產品、手術類型、類型、技術、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

“按產品分類，膝關節關節重建設備領域在 2023 年佔據最大佔有率。”

智慧膝關節關節重建手術的推出、肥胖人口的增加以及意識的提高預計將推動這一領域的成長。借助機器人平台的膝關節關節重建手術的發展顯著改善了患者的治療效果，是推動這一領域發展的關鍵因素之一。例如，美國史賽克公司 (Stryker Corporation) 的 Mako 全膝關節置換術可能比傳統手術帶來更少的不適感和更短的恢復期。

“根據手術類型，整體置換術部分將在 2023 年佔據最大的市場佔有率。”

膝關節和髖關節置換術等關節重建關節重建的興起，以及新推出的植入的獨特性能（如長壽命和耐腐蝕性）正在推動這一領域的成長。資金籌措機會的增加和機器人手術的進步正在推動這一領域的成長。此外，新的創新植入有助於減輕疼痛、減少後續就診和修復手術，從而支持市場成長。

“根據最終用戶，門診護理中心和創傷中心部分預計在預測期內將實現顯著的複合年成長率。”

根據 Definitive Healthcare 的數據，2018 年至 2022 年間，門診手術中心執行的膝關節關節重建手術數量將增加 304%。預計門診護理中心的可及性和成本效益的提高將推動這一領域的成長。此外，人們對微創手術技術的日益青睞預計將推動該領域的成長。

“預計亞太市場將在預測期內呈現最高成長。”

2023 年，北美佔據了很大佔有率。預計亞太地區關節重建市場的複合年成長率最高。投資數量的增加、醫療保健基礎設施的改善以及新興國家投資的不斷成長，極大地支持了對關節重建設備的需求。此外，市場領導者正在做出巨大努力，加強其在亞太市場的影響力，以滿足日益成長的關節關節重建手術需求。根據國際骨質疏鬆基金會的數據，到 2050 年，預計超過一半的髖部骨折將因骨質疏鬆而引起。

本報告對全球關節重建設備市場進行了深入分析，包括關鍵促進因素和限制因素、競爭格局和未來趨勢。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

  • 關節重建設備市場概況
  • 北美關節重建設備市場（按產品分類）（2024 年和 2030 年）
  • 歐洲關節重建器材市場按手術類型分類（2024 年和 2030 年）
  • 亞太地區關節重建設備市場（按最終用戶分類） (2024 年和 2030 年)
  • 關節重建設備市場地理分佈

第5章 市場概況

  • 介紹
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 任務
  • 價值鏈分析
    • 研究與產品開發
    • 原物料採購及製造
    • 分銷、行銷、銷售和售後服務
  • 供應鏈分析
    • 製造商
    • 最終用戶
  • 生態系分析
  • 監管分析
    • 監管機構、政府機構和其他組織
    • 法規結構
    • 監管部門核准
  • 贖回情況
  • 投資金籌措場景
  • 定價分析
    • 主要企業的平均銷售價格
    • 各地區平均銷售價格趨勢
  • 貿易分析
    • 導入資料
    • 匯出資料
  • 專利分析
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 重大會議和活動（2024-2025 年）
  • 案例研究分析
  • 技術分析
    • 關鍵技術
    • 互補技術
    • 相關技術
  • 影響客戶業務的趨勢/干擾
  • 未滿足的需求
  • 人工智慧對關節重建設備市場的影響

第6章關節重建設備市場（依產品）

  • 介紹
  • 膝關節關節重建設備
  • 髖關節置換術設備
  • 肩關節關節重建設備
  • 踝關節關節重建設備
  • 手肘關節關節重建設備
  • 手腕關節置換術設備
  • 其他關節重建裝置
  • 骨移植替代品

第 7 章關節重建器械市場（依手術類型）

  • 介紹
  • 全面置換術
  • 部分置換術
  • 重新置換手術

第 8 章關節重建器材市場（按類型）

  • 介紹
  • 水泥固定
  • 非骨水泥固定
  • 混合固定
  • 反向混合固定

第9章關節重建器材市場（依技術分類）

  • 介紹
  • 傳統手術
  • 微創手術
  • 電腦導航手術

第 10 章關節重建設備市場（依最終用戶分類）

  • 介紹
  • 醫院和外科中心
  • 門診護理中心/創傷中心
  • 整形外科門診

第 11 章關節重建設備市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他中東和非洲地區

第12章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢（2021-2024）
  • 收益分析（2019-2023）
  • 市場佔有率分析（2023 年）
  • 公司估值和財務指標
  • 品牌/產品比較
  • 企業評估矩陣：主要企業（2023 年）
  • 公司評估矩陣：Start-Ups/中小企業（2023 年）
  • 競爭場景

第13章 公司簡介

  • 主要企業
    • ZIMMER BIOMET
    • STRYKER
    • JOHNSON & JOHNSON MEDTECH
    • SMITH+NEPHEW
    • B. BRAUN
    • GLOBUS MEDICAL
    • ARTHREX, INC.
    • ENOVIS
    • ACUMED LLC
    • ORTHOFIX MEDICAL INC.
    • MICROPORT SCIENTIFIC CORPORATION
    • CONMED CORPORATION
    • MEDACTA INTERNATIONAL
    • PARAGON 28, INC.
    • MERIL LIFE SCIENCES PVT. LTD.
    • GPC MEDICAL LTD.
    • MAXX ORTHOPEDICS, INC.
    • AUXEIN
    • NORAKER
    • NEXTSTEP ARTHROPEDIX
    • EXACTECH, INC.
  • 其他公司
    • FH ORTHO
    • SYMBIOS ORTHOPEDIE SA
    • MADISON ORTHO
    • GREEN SURGICALS PVT. LTD.
    • SIORA SURGICAL PVT. LTD.
    • ORTHOPEDIATRICS CORP.
    • RESTOR3D
    • DOUBLE MEDICAL TECHNOLOGY INC.
    • TREACE MEDICAL CONCEPTS, INC.
    • AK MEDICAL

第14章 附錄

Product Code: MD 9286

The global joint replacement devices market is expected to reach 31.09 billion by 2030 from USD 23.42 billion in 2024, at a CAGR of 4.8% from 2024 to 2030. Technological advancements such as use of 3D printing with the manufacturing process, introduction of smart implants, and increased access to latest and innovative implants supports the growth of joint replacement devices market. Further, rising number of sport injuries and increased incidence of accidents that may result in fractures damage to the joints has resulted in rising demand for the joint replacement devices.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD)
SegmentsProduct, surgery type, type, technique, end user, and region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The knee replacement devices segment of product segment held the largest share of the market in 2023"

The joint replacement devices market is segmented based on product into knee replacement devices, hip replacement devices, shoulder replacement devices, elbow replacement devices, ankle replacement devices, wrist replacement devices, other replacement devices, and bone graft substitutes. The knee replacement devices accounted for a the highest share in 2023. Launch of smart knee replacement devices, rise in number of obese population, and increasing awareness initiatives is anticipated to fuel the growth of the segment. Developments knee replacement procedures with an assistance of robotic platform improves patient outcome significtly and is one of the important factors propelling the segment. For instance, the Mako Total Knee Replacement from Stryker Corporation (US) may result in less discomfort and a reduced recovery period as compared to traditional surgery.

"The total replacement segment of surgery type segment held the largest share of the market in 2023"

The joint replacement devices market can be segmented based on surgery type into total replacement, partial replacement, and revision replacement. Growing number for joint replacement surgeries such as knee and hip replacement surgeries and the unique properties of newly launched implants such as longevity and resistance to corrosion drives the segment growth. Increasing funding opportunities and advancements in robotic surgery drives the segment growth. Furthermore, the new and innovative implants assist with reduction in pain, fewer follow ups, reduced revisions, etc. that ultimately supports the growth of the market.

"The ambulatory care centers and trauma units segment for the end user segment is projected to register a significant CAGR during the forecast period."

The joint replacement devices market is segmented by end-users into hospitals & surgical centers, ambulatory care centers & trauma units, and orthopedic clinics. The ambulatory care centers and trauma units are expected to witness a significant growth during the forecast period. According to Definitive Healthcare there has been a 304% rise in knee replacement surgical procedures performed in ambulatory surgery centers during the period of 2018-2022. Increased accessibility and cost effectiveness at ambulatory care centers anticipated to propel the segment growth. Furthermore, rising preference for minimally invasive surgical techniques is expected to support the growth of this segment.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in joint replacement devices market. Increasing number of investments, improved healthcare infrastructure and increasing investments in the emerging countries, majorly supports the demand for joint replacement devices. Furthermore, market leaders taking remarkable efforts to strengthen their reach in the Asia Pacific market to meet the growing demand for joint replacement devices. According to International Osteoporosis Foundation, more than 50% of osteoporotic hip fractures are expected to occur by 2050.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
  • By Designation: Director-level-10%, C-level-14%, and Others-76%
  • By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and Middle East & Africa - 2%

The prominent players in the joint replacement devices market are as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany), Arthrex, Inc.(US), Enovis (US), Globus Medical, Inc. (US), Acumed LLC (US), Orthofix Medical Inc.(US) , MicroPort Scientiifc Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US) and, Meril Life Sciences Pvt. Ltd. (India).

The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments, and key market strategies.

Research Coverage

This report studies the joint replacement devices market based on product, surgery type, type, technique, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall joint replacement devices market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing demand for minimally invasive orthopaedic surgical procedures and rising number of sports injuries, increasing prevalence of orthopaedic diseases and disorders, and increasing research funding and initiatives adopted by orthopaedic manufacturers to promoted brand awareness, increasing adoption of sensor-based implants), restraints (risk and complications associated with orthopaedic surgical procedures, high costs associated with orthopaedic treatments, reduced reimbursements for orthopedic surgical procedures), opportunities (rising number of hospitals and shift towards outpatient care, advancement in robotic assisted orthopaedic surgeries and 3D printing), and challenges (dearth of skilled orthopaedic surgeons) influencing the growth of the joint replacement devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the joint replacement devices market
  • Market Development: Comprehensive information about lucrative markets-the report analyses the joint replacement devices market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the joint replacement devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources for secondary research
      • 2.1.1.2 Key objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key primary insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Company revenue estimation approach
      • 2.2.1.2 Customer-based market estimation
      • 2.2.1.3 Growth forecast approach
      • 2.2.1.4 CAGR projections
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
    • 2.5.1 PARAMETRIC ASSUMPTIONS
    • 2.5.2 GROWTH RATE ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 JOINT REPLACEMENT DEVICES MARKET OVERVIEW
  • 4.2 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
  • 4.3 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2024 VS. 2030 (USD MILLION)
  • 4.4 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • 4.5 GEOGRAPHIC SNAPSHOT OF JOINT REPLACEMENT DEVICES MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of orthopedic diseases and disorders
      • 5.2.1.2 Increasing demand for minimally invasive surgery
      • 5.2.1.3 Rising adoption of sensor-based implants
      • 5.2.1.4 Rising number of sports injuries
      • 5.2.1.5 Increasing research funding
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risks and complications associated with orthopedic surgical procedures
      • 5.2.2.2 Reduced reimbursement rates for orthopedic surgeries
      • 5.2.2.3 High cost of orthopedic surgery
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Advancements in robotic surgery and 3D printing
      • 5.2.3.2 Growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled orthopedic surgeons
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
    • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.4 SUPPLY CHAIN ANALYSIS
    • 5.4.1 MANUFACTURERS
      • 5.4.1.1 Prominent companies
      • 5.4.1.2 Small and medium-sized enterprises
    • 5.4.2 END USERS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 REGULATORY ANALYSIS
    • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.6.2 REGULATORY FRAMEWORK
      • 5.6.2.1 North America
        • 5.6.2.1.1 US
        • 5.6.2.1.2 Canada
      • 5.6.2.2 Europe
      • 5.6.2.3 Asia Pacific
        • 5.6.2.3.1 Japan
        • 5.6.2.3.2 China
        • 5.6.2.3.3 India
      • 5.6.2.4 Latin America
        • 5.6.2.4.1 Brazil
    • 5.6.3 REGULATORY APPROVALS
  • 5.7 REIMBURSEMENT SCENARIO
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
    • 5.9.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA
    • 5.10.2 EXPORT DATA
  • 5.11 PATENT ANALYSIS
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 CASE STUDY 1: DIGITAL PLATFORM DESIGNED TO IMPROVE PATIENT CARE PATHWAYS
    • 5.15.2 CASE STUDY 2: PARTIAL KNEE ARTHROPLASTY PERFORMED WITH ROSA PARTIAL KNEE SYSTEM
    • 5.15.3 CASE STUDY 3: ACCURATE DATA GENERATION WITH SHAPEGRABBER 3D
  • 5.16 TECHNOLOGY ANALYSIS
    • 5.16.1 KEY TECHNOLOGIES
      • 5.16.1.1 3D printing/additive manufacturing
    • 5.16.2 COMPLEMENTARY TECHNOLOGIES
      • 5.16.2.1 Robotic orthopedic surgery
    • 5.16.3 ADJACENT TECHNOLOGIES
      • 5.16.3.1 Diagnostic imaging
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.18 UNMET NEEDS
  • 5.19 IMPACT OF AI ON JOINT REPLACEMENT DEVICES MARKET
    • 5.19.1 KEY USE CASES

6 JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 KNEE REPLACEMENT DEVICES
    • 6.2.1 TOTAL KNEE REPLACEMENT DEVICES
      • 6.2.1.1 Ongoing innovation in knee implants to support market growth
    • 6.2.2 PARTIAL KNEE REPLACEMENT DEVICES
      • 6.2.2.1 Quick recovery and shorter hospital stays to drive segmental growth
    • 6.2.3 REVISION KNEE REPLACEMENT DEVICES
      • 6.2.3.1 Rising incidence of obesity and ongoing technological advancements to fuel growth
  • 6.3 HIP REPLACEMENT DEVICES
    • 6.3.1 TOTAL HIP REPLACEMENT DEVICES
      • 6.3.1.1 Increasing number of hip fractures and increasing success rates of hip arthroplasty to support market
    • 6.3.2 PARTIAL HIP REPLACEMENT DEVICES
      • 6.3.2.1 Increasing geriatric population and rising focus on minimally invasive surgeries to boost market
    • 6.3.3 REVISION HIP REPLACEMENT DEVICES
      • 6.3.3.1 Improved longevity and better patient outcomes to drive growth
    • 6.3.4 HIP RESURFACING DEVICES
      • 6.3.4.1 Improved stability and faster recovery to boost segment
  • 6.4 SHOULDER REPLACEMENT DEVICES MARKET
    • 6.4.1 TOTAL SHOULDER REPLACEMENT DEVICES
      • 6.4.1.1 Increasing launch of new shoulder replacement devices to support market growth
    • 6.4.2 PARTIAL SHOULDER REPLACEMENT DEVICES
      • 6.4.2.1 Growing incidence of rotator cuff disorders to drive growth
    • 6.4.3 REVERSE SHOULDER REPLACEMENT DEVICES
      • 6.4.3.1 Rising number of reverse shoulder arthroplasty procedures to boost market
  • 6.5 ANKLE REPLACEMENT DEVICES
    • 6.5.1 TOTAL ANKLE REPLACEMENT DEVICES
      • 6.5.1.1 Growing number of ankle replacement procedures to fuel uptake
    • 6.5.2 ANKLE FUSION/FIXATION DEVICES
      • 6.5.2.1 Cost-effectiveness and improved surgical outcomes to propel market
  • 6.6 ELBOW REPLACEMENT DEVICES
    • 6.6.1 INCREASING FREQUENCY OF ELBOW JOINT FRACTURES AND GROWTH IN ELDERLY POPULATION TO DRIVE MARKET
  • 6.7 WRIST REPLACEMENT DEVICES
    • 6.7.1 GROWING NUMBER OF WRIST REPLACEMENT PROCEDURES TO DRIVE MARKET GROWTH
  • 6.8 OTHER JOINT REPLACEMENT DEVICES
  • 6.9 BONE GRAFT SUBSTITUTES
    • 6.9.1 COST-EFFECTIVE AND EASY AVAILABILITY OF BONE GRAFT SUBSTITUTES TO PROPEL MARKET

7 JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE

  • 7.1 INTRODUCTION
  • 7.2 TOTAL REPLACEMENT PROCEDURES
    • 7.2.1 INCREASING NUMBER OF HIP AND KNEE REPLACEMENT SURGERIES TO DRIVE MARKET GROWTH
  • 7.3 PARTIAL REPLACEMENT PROCEDURES
    • 7.3.1 INCREASING INCIDENCE OF BONE-RELATED DISORDERS AND QUICKER RECOVERY PERIODS TO BOOST DEMAND
  • 7.4 REVISION REPLACEMENT PROCEDURES
    • 7.4.1 DEVELOPMENT OF SPECIALIZED IMPLANTS TO FUEL DEMAND

8 JOINT REPLACEMENT DEVICES MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 CEMENTED FIXATION
    • 8.2.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES AND DECREASE IN REVISION PROCEDURES TO DRIVE MARKET
  • 8.3 CEMENTLESS FIXATION
    • 8.3.1 IMPROVED STABILITY AND DURABILITY TO FUEL SEGMENT GROWTH
  • 8.4 HYBRID FIXATION
    • 8.4.1 IMPROVED BONE GROWTH AND RAPID RECOVERY TO DRIVE MARKET
  • 8.5 REVERSE HYBRID FIXATION
    • 8.5.1 RISING INCIDENCE OF OSTEOARTHRITIS AND INCREASING NUMBER OF HIP REPLACEMENT SURGERIES TO FUEL MARKET GROWTH

9 JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE

  • 9.1 INTRODUCTION
  • 9.2 TRADITIONAL SURGERY
    • 9.2.1 COST-EFFECTIVENESS AND HIGHER FAMILIARITY TO PROPEL MARKET GROWTH
  • 9.3 MINIMALLY INVASIVE SURGERY
    • 9.3.1 REDUCED PAIN AND FASTER RECOVERY TO DRIVE DEMAND
  • 9.4 COMPUTER-ASSISTED SURGERY
    • 9.4.1 IMPROVED ACCURACY AND REAL-TIME GUIDANCE TO FUEL GROWTH

10 JOINT REPLACEMENT DEVICES MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & SURGICAL CENTERS
    • 10.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES TO DRIVE MARKET
  • 10.3 AMBULATORY CARE CENTERS & TRAUMA UNITS
    • 10.3.1 COST-EFFECTIVE TREATMENTS OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH
  • 10.4 ORTHOPEDIC CLINICS
    • 10.4.1 RISING NUMBER OF ORTHOPEDIC CLINICS TO SUPPORT MARKET GROWTH

11 JOINT REPLACEMENT DEVICES MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Growing focus on launching technologically advanced hybrid implants to drive market
    • 11.2.3 CANADA
      • 11.2.3.1 Rising incidence of degenerative bone diseases to support market growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Increasing focus on commercialization of joint replacement devices to boost demand
    • 11.3.3 FRANCE
      • 11.3.3.1 Increasing cases of obesity and subsequent rise in osteoporosis to drive market
    • 11.3.4 UK
      • 11.3.4.1 Increasing awareness of orthopedic conditions to boost demand
    • 11.3.5 ITALY
      • 11.3.5.1 Growing focus on preventive care for musculoskeletal injuries to drive market
    • 11.3.6 SPAIN
      • 11.3.6.1 Rising preference for MIS techniques to support market growth
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Rapidly growing geriatric population to propel market
    • 11.4.3 CHINA
      • 11.4.3.1 Expanding target patient population to drive market
    • 11.4.4 INDIA
      • 11.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Favorable government initiatives for bone health awareness to fuel market
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Favorable government support for healthcare access to support market growth
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Expansion of global market players for advanced product commercialization to boost demand
    • 11.5.3 MEXICO
      • 11.5.3.1 Favorable investments for medical device manufacturers to support market growth
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Rising focus on in-house manufacturing of advanced orthopedic devices to support market growth
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 BRAND/PRODUCT COMPARISON
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.7.5.1 Company footprint
      • 12.7.5.2 Region footprint
      • 12.7.5.3 Type footprint
      • 12.7.5.4 Surgery type footprint
      • 12.7.5.5 Type footprint
      • 12.7.5.6 Technique footprint
      • 12.7.5.7 End-user footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.8.5.1 Detailed list of key startups/SMEs
      • 12.8.5.2 Competitive benchmarking of startups/SMEs
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 ZIMMER BIOMET
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches and approvals
        • 13.1.1.3.2 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 STRYKER
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches and approvals
        • 13.1.2.3.2 Deals
        • 13.1.2.3.3 Expansions
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 JOHNSON & JOHNSON MEDTECH
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Product launches and approvals
        • 13.1.3.3.2 Deals
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 SMITH+NEPHEW
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches and approvals
        • 13.1.4.3.2 Deals
        • 13.1.4.3.3 Expansions
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Key strengths
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 B. BRAUN
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Right to win
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses and competitive threats
    • 13.1.6 GLOBUS MEDICAL
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches and approvals
        • 13.1.6.3.2 Deals
    • 13.1.7 ARTHREX, INC.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
    • 13.1.8 ENOVIS
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches and approvals
        • 13.1.8.3.2 Deals
        • 13.1.8.3.3 Expansions
    • 13.1.9 ACUMED LLC
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches and approvals
        • 13.1.9.3.2 Deals
        • 13.1.9.3.3 Expansions
    • 13.1.10 ORTHOFIX MEDICAL INC.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Product launches and approvals
        • 13.1.10.3.2 Deals
    • 13.1.11 MICROPORT SCIENTIFIC CORPORATION
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Product launches and approvals
        • 13.1.11.3.2 Deals
    • 13.1.12 CONMED CORPORATION
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Deals
    • 13.1.13 MEDACTA INTERNATIONAL
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Product launches and approvals
        • 13.1.13.3.2 Deals
        • 13.1.13.3.3 Expansions
    • 13.1.14 PARAGON 28, INC.
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Product launches and approvals
        • 13.1.14.3.2 Deals
    • 13.1.15 MERIL LIFE SCIENCES PVT. LTD.
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Expansions
    • 13.1.16 GPC MEDICAL LTD.
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products offered
    • 13.1.17 MAXX ORTHOPEDICS, INC.
      • 13.1.17.1 Business overview
      • 13.1.17.2 Products offered
      • 13.1.17.3 Recent developments
        • 13.1.17.3.1 Product launches and approvals
        • 13.1.17.3.2 Deals
    • 13.1.18 AUXEIN
      • 13.1.18.1 Business overview
      • 13.1.18.2 Products offered
      • 13.1.18.3 Recent developments
        • 13.1.18.3.1 Deals
    • 13.1.19 NORAKER
      • 13.1.19.1 Business overview
      • 13.1.19.2 Products offered
      • 13.1.19.3 Recent developments
        • 13.1.19.3.1 Product launches and approvals
        • 13.1.19.3.2 Deals
    • 13.1.20 NEXTSTEP ARTHROPEDIX
      • 13.1.20.1 Business overview
      • 13.1.20.2 Products offered
    • 13.1.21 EXACTECH, INC.
      • 13.1.21.1 Business overview
      • 13.1.21.2 Products offered
      • 13.1.21.3 Recent developments
        • 13.1.21.3.1 Product launches and approvals
        • 13.1.21.3.2 Deals
  • 13.2 OTHER PLAYERS
    • 13.2.1 FH ORTHO
    • 13.2.2 SYMBIOS ORTHOPEDIE S.A.
    • 13.2.3 MADISON ORTHO
    • 13.2.4 GREEN SURGICALS PVT. LTD.
    • 13.2.5 SIORA SURGICAL PVT. LTD.
    • 13.2.6 ORTHOPEDIATRICS CORP.
    • 13.2.7 RESTOR3D
    • 13.2.8 DOUBLE MEDICAL TECHNOLOGY INC.
    • 13.2.9 TREACE MEDICAL CONCEPTS, INC.
    • 13.2.10 AK MEDICAL

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 JOINT REPLACEMENT DEVICES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 JOINT REPLACEMENT DEVICES MARKET: PARAMETRIC ASSUMPTIONS
  • TABLE 3 JOINT REPLACEMENT DEVICES MARKET: RISK ASSESSMENT
  • TABLE 4 JOINT REPLACEMENT DEVICES MARKET: GRANTS AND FUNDING
  • TABLE 5 DIFFERENCES IN INFLATION-ADJUSTED MEDICARE REIMBURSEMENT
  • TABLE 6 JOINT REPLACEMENT DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 7 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 14 US: CLASSIFICATION OF JOINT REPLACEMENT DEVICES
  • TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
  • TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 18 REGULATORY APPROVALS FOR JOINT REPLACEMENT DEVICES, BY COUNTRY
  • TABLE 19 US: MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC IMPLANTATION SERVICES, 2023 (DRG CODES)
  • TABLE 20 US: MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC IMPLANTATION SERVICES, 2023 (CPT CODES)
  • TABLE 21 CANADA: MPS BILLING CODES, 2023
  • TABLE 22 GERMANY: OPS CODES, 2023
  • TABLE 23 UK: OPCS CODES, 2023
  • TABLE 24 AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES, BY KEY PLAYER, 2023 (USD)
  • TABLE 25 AVERAGE SELLING PRICE TREND OF JOINT REPLACEMENT DEVICES, BY REGION, 2021-2023 (USD)
  • TABLE 26 IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 27 EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 28 LIST OF MAJOR PATENT INNOVATIONS AND REGISTRATIONS, JANUARY 2014-SEPTEMBER 2024
  • TABLE 29 JOINT REPLACEMENT DEVICES MARKET: PORTER'S FIVE FORCES
  • TABLE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • TABLE 31 KEY BUYING CRITERIA, BY END USER
  • TABLE 32 JOINT REPLACEMENT DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 33 JOINT REPLACEMENT DEVICES MARKET: CURRENT UNMET NEEDS
  • TABLE 34 JOINT REPLACEMENT DEVICES MARKET: INTENSITY OF CURRENT UNMET NEEDS
  • TABLE 35 JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 36 JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 37 JOINT REPLACEMENT PROCEDURES DATA, (2023 VS 2030)
  • TABLE 38 KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 39 KNEE REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 40 TOTAL KNEE REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 41 PARTIAL KNEE REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 42 REVISION KNEE REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 43 HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 44 HIP REPLACEMENT DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 45 TOTAL HIP REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 46 PARTIAL HIP REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 47 REVISION HIP REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 48 HIP RESURFACING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 49 SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 50 SHOULDER REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 51 TOTAL SHOULDER REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 52 PARTIAL SHOULDER REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 53 REVERSE SHOULDER REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 54 ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 55 ANKLE REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 56 TOTAL ANKLE REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 57 ANKLE FUSION/FIXATION DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 58 ELBOW REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 59 WRIST REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 60 OTHER JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 61 BONE GRAFT SUBSTITUTES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 62 JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022-2030 (USD MILLION)
  • TABLE 63 JOINT REPLACEMENT DEVICES MARKET FOR TOTAL REPLACEMENT PROCEDURES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 64 JOINT REPLACEMENT DEVICES MARKET FOR PARTIAL REPLACEMENT PROCEDURES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 65 JOINT REPLACEMENT DEVICES MARKET FOR REVISION REPLACEMENT PROCEDURES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 66 JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 67 JOINT REPLACEMENT DEVICES MARKET FOR CEMENTED FIXATION, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 68 JOINT REPLACEMENT DEVICES MARKET FOR CEMENTLESS FIXATION, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 69 JOINT REPLACEMENT DEVICES MARKET FOR HYBRID FIXATION, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 70 JOINT REPLACEMENT DEVICES MARKET FOR REVERSE HYBRID FIXATION, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 71 JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
  • TABLE 72 JOINT REPLACEMENT DEVICES MARKET FOR TRADITIONAL SURGERY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 73 JOINT REPLACEMENT DEVICES MARKET FOR MINIMALLY INVASIVE SURGERY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 74 JOINT REPLACEMENT DEVICES MARKET FOR COMPUTER-ASSISTED SURGERY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 75 JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 76 JOINT REPLACEMENT DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 77 JOINT REPLACEMENT DEVICES MARKET FOR AMBULATORY CARE CENTERS & TRAUMA UNITS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 78 JOINT REPLACEMENT DEVICES MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 79 JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 84 NORTH AMERICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 85 NORTH AMERICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022-2030 (USD MILLION)
  • TABLE 87 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
  • TABLE 89 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 91 US: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 92 US: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 93 US: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 94 US: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 95 US: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 96 CANADA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 97 CANADA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 98 CANADA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 99 CANADA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 100 CANADA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 101 EUROPE: KEY MACROINDICATORS
  • TABLE 102 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 103 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 104 EUROPE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 105 EUROPE: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 106 EUROPE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 107 EUROPE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 108 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022-2030 (USD MILLION)
  • TABLE 109 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 110 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
  • TABLE 111 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 112 GERMANY: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 113 GERMANY: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 114 GERMANY: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 115 GERMANY: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 116 GERMANY: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 117 FRANCE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 118 FRANCE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 119 FRANCE: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 120 FRANCE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 121 FRANCE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 122 UK: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 123 UK: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 124 UK: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 125 UK: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 126 UK: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 127 ITALY: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 128 ITALY: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 129 ITALY: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 130 ITALY: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 ITALY: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 132 SPAIN: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 133 SPAIN: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 134 SPAIN: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 135 SPAIN: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 136 SPAIN: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 143 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

022-2030 (USD MILLION)

  • TABLE 147 ASIA PACIFIC: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022-2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 153 JAPAN: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 154 JAPAN: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 155 JAPAN: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 156 JAPAN: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 157 JAPAN: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 158 CHINA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 159 CHINA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 160 CHINA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 161 CHINA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 162 CHINA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 163 INDIA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 164 INDIA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 165 INDIA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 166 INDIA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 167 INDIA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 168 AUSTRALIA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 169 AUSTRALIA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 170 AUSTRALIA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 171 AUSTRALIA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 172 AUSTRALIA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 173 SOUTH KOREA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 174 SOUTH KOREA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 175 SOUTH KOREA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 176 SOUTH KOREA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 177 SOUTH KOREA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 183 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 184 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 185 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 LATIN AMERICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 190 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022-2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 194 BRAZIL: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 195 BRAZIL: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 196 BRAZIL: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 197 BRAZIL: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 198 BRAZIL: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 199 MEXICO: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 200 MEXICO: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 201 MEXICO: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 202 MEXICO: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 203 MEXICO: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 204 REST OF LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 205 REST OF LATIN AMERICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 206 REST OF LATIN AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 207 REST OF LATIN AMERICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 209 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 210 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 211 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 212 MIDDLE EAST & AFRICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 213 MIDDLE EAST & AFRICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022-2030 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 220 GCC COUNTRIES: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 221 GCC COUNTRIES: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 225 REST OF MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 226 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 227 REST OF MIDDLE EAST & AFRICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 228 REST OF MIDDLE EAST & AFRICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 229 REST OF MIDDLE EAST & AFRICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 230 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET, 2021-2024
  • TABLE 231 JOINT REPLACEMENT DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 232 JOINT REPLACEMENT DEVICES MARKET: REGION FOOTPRINT
  • TABLE 233 JOINT REPLACEMENT DEVICES MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 234 JOINT REPLACEMENT DEVICES MARKET: SURGERY TYPE FOOTPRINT
  • TABLE 235 JOINT REPLACEMENT DEVICES MARKET: TYPE FOOTPRINT
  • TABLE 236 JOINT REPLACEMENT DEVICES MARKET: TECHNIQUE FOOTPRINT
  • TABLE 237 JOINT REPLACEMENT DEVICES MARKET: END-USER FOOTPRINT
  • TABLE 238 JOINT REPLACEMENT DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SMES
  • TABLE 239 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES (1/4)
  • TABLE 240 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING O F KEY STARTUPS/SMES (2/4)
  • TABLE 241 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES (3/4)
  • TABLE 242 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES (4/4)
  • TABLE 243 JOINT REPLACEMENT DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 244 JOINT REPLACEMENT DEVICES MARKET: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 245 JOINT REPLACEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED
  • TABLE 248 ZIMMER BIOMET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 249 ZIMMER BIOMET: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 250 STRYKER: COMPANY OVERVIEW
  • TABLE 251 STRYKER: PRODUCTS OFFERED
  • TABLE 252 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 253 STRYKER: DEALS, JANUARY 2021- DECEMBER 2024
  • TABLE 254 STRYKER: EXPANSIONS, JANUARY 2021- DECEMBER 2024
  • TABLE 255 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
  • TABLE 256 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
  • TABLE 257 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 258 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 259 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 260 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 261 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- DECEMBER 2024
  • TABLE 262 SMITH+NEPHEW: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 263 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 264 B. BRAUN: COMPANY OVERVIEW
  • TABLE 265 B. BRAUN: PRODUCTS OFFERED
  • TABLE 266 GLOBUS MEDICAL: COMPANY OVERVIEW
  • TABLE 267 GLOBUS MEDICAL: PRODUCTS OFFERED
  • TABLE 268 GLOBUS MEDICAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 269 GLOBUS MEDICAL: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 270 ARTHREX, INC.: COMPANY OVERVIEW
  • TABLE 271 ARTHREX, INC.: PRODUCTS OFFERED
  • TABLE 272 ENOVIS: COMPANY OVERVIEW
  • TABLE 273 ENOVIS: PRODUCTS OFFERED
  • TABLE 274 ENOVIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 275 ENOVIS: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 276 ENOVIS: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 277 ACUMED LLC: COMPANY OVERVIEW
  • TABLE 278 ACUMED LLC: PRODUCTS OFFERED
  • TABLE 279 ACUMED LLC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 280 ACUMED: DEALS, JANUARY 2021- DECEMBER 2024
  • TABLE 281 ACUMED: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 282 ORTHOFIX MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 283 ORTHOFIX MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 284 ORTHOFIX MEDICAL INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- DECEMBER 2024
  • TABLE 285 ORTHOFIX MEDICAL INC.: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 286 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 287 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 288 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- DECEMBER 2024
  • TABLE 289 MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 290 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 291 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 292 CONMED CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 293 MEDACTA INTERNATIONAL: COMPANY OVERVIEW
  • TABLE 294 MEDACTA INTERNATIONAL: PRODUCTS OFFERED
  • TABLE 295 MEDACTA INTERNATIONAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- DECEMBER 2024
  • TABLE 296 MEDACTA INTERNATIONAL: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 297 MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2021-DECEMBER 2024
  • TABLE 298 PARAGON 28, INC.: COMPANY OVERVIEW
  • TABLE 299 PARAGON 28, INC.: PRODUCTS OFFERED
  • TABLE 300 PARAGON 28, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- DECEMBER 2024
  • TABLE 301 PARAGON 28, INC.: DEALS, JANUARY 2021- DECEMBER 2024
  • TABLE 302 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 303 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
  • TABLE 304 MERIL LIFE SCIENCES PVT. LTD.: EXPANSIONS, JANUARY 2021- DECEMBER 2024
  • TABLE 305 GPC MEDICAL LTD.: COMPANY OVERVIEW
  • TABLE 306 GPC MEDICAL LTD.: PRODUCTS OFFERED
  • TABLE 307 MAXX ORTHOPEDICS, INC.: COMPANY OVERVIEW
  • TABLE 308 MAXX ORTHOPEDICS, INC.: PRODUCTS OFFERED
  • TABLE 309 MAXX ORTHOPEDICS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- DECEMBER 2024
  • TABLE 310 MAXX ORTHOPEDICS, INC.: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 311 AUXEIN: COMPANY OVERVIEW
  • TABLE 312 AUXEIN: PRODUCTS OFFERED
  • TABLE 313 AUXEIN: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 314 NORAKER: COMPANY OVERVIEW
  • TABLE 315 NORAKER: PRODUCTS OFFERED
  • TABLE 316 NORAKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
  • TABLE 317 NORAKER: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 318 NEXTSTEP ARTHROPEDIX: COMPANY OVERVIEW
  • TABLE 319 NEXTSTEP ARTHROPEDIX: PRODUCTS OFFERED
  • TABLE 320 EXACTECH, INC.: COMPANY OVERVIEW
  • TABLE 321 EXACTECH, INC.: PRODUCTS OFFERED
  • TABLE 322 EXACTECH, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- DECEMBER 2024
  • TABLE 323 EXACTECH, INC.: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 324 FH ORTHO: COMPANY OVERVIEW
  • TABLE 325 SYMBIOS ORTHOPEDIE S.A.: COMPANY OVERVIEW
  • TABLE 326 MADISON ORTHO: COMPANY OVERVIEW
  • TABLE 327 GREEN SURGICALS PVT. LTD.: COMPANY OVERVIEW
  • TABLE 328 SIORA SURGICAL PVT. LTD.: COMPANY OVERVIEW
  • TABLE 329 ORTHOPEDIATRICS CORP.: COMPANY OVERVIEW
  • TABLE 330 RESTOR3D: COMPANY OVERVIEW
  • TABLE 331 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW
  • TABLE 332 TREACE MEDICAL CONCEPTS, INC.: COMPANY OVERVIEW
  • TABLE 333 AK MEDICAL: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 JOINT REPLACEMENT DEVICES MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
  • FIGURE 2 JOINT REPLACEMENT DEVICES MARKET: YEARS CONSIDERED
  • FIGURE 3 JOINT REPLACEMENT DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 4 JOINT REPLACEMENT DEVICES MARKET: KEY PRIMARY SOURCES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
  • FIGURE 5 JOINT REPLACEMENT DEVICES: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 9 JOINT REPLACEMENT DEVICES MARKET: COMPANY REVENUE ESTIMATION
  • FIGURE 10 JOINT REPLACEMENT DEVICES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 JOINT REPLACEMENT DEVICES MARKET: DATA TRIANGULATION
  • FIGURE 13 JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 14 JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF JOINT REPLACEMENT DEVICES MARKET
  • FIGURE 19 INCREASING GERIATRIC POPULATION AND RISING RESEARCH FUNDING TO DRIVE MARKET
  • FIGURE 20 HIP REPLACEMENT DEVICES TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
  • FIGURE 21 TOTAL REPLACEMENT PROCEDURES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
  • FIGURE 22 HOSPITALS & SURGICAL CENTERS TO COMMAND LARGEST MARKET SHARE FROM 2024 TO 2030
  • FIGURE 23 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 24 JOINT REPLACEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 JOINT REPLACEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 26 JOINT REPLACEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 27 JOINT REPLACEMENT DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
  • FIGURE 29 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 30 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2019-2023
  • FIGURE 32 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 33 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 34 AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES, BY PRODUCT, 2023 (USD)
  • FIGURE 35 AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES, BY REGION, 2023 (USD)
  • FIGURE 36 PATENT ANALYSIS FOR JOINT REPLACEMENT DEVICES MARKET (JANUARY 2014-SEPTEMBER 2024)
  • FIGURE 37 JOINT REPLACEMENT DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF J OINT REPLACEMENT DEVICES
  • FIGURE 39 KEY BUYING CRITERIA, BY END USER
  • FIGURE 40 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 41 MARKET POTENTIAL OF AI IN JOINT REPLACEMENT DEVICES MARKET
  • FIGURE 42 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 43 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 44 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET, 2019-2023
  • FIGURE 45 JOINT REPLACEMENT DEVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 46 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
  • FIGURE 48 JOINT REPLACEMENT DEVICES MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 49 JOINT REPLACEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 50 JOINT REPLACEMENT DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 51 JOINT REPLACEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 52 ZIMMER BIOMET: COMPANY SNAPSHOT (2023)
  • FIGURE 53 STRYKER: COMPANY SNAPSHOT (2023)
  • FIGURE 54 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023)
  • FIGURE 55 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
  • FIGURE 56 B. BRAUN: COMPANY SNAPSHOT (2023)
  • FIGURE 57 GLOBUS MEDICAL: COMPANY SNAPSHOT (2023)
  • FIGURE 58 ENOVIS: COMPANY SNAPSHOT (2023)
  • FIGURE 59 ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 62 MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2023)
  • FIGURE 63 PARAGON 28, INC.: COMPANY SNAPSHOT (2023)